Terms: = Lung cancer AND JUN, P05412, 3725, ENSG00000177606, AP1, c-Jun
1023 results:
1. Exploring the Mechanism of Zilongjin in Treating lung Adenocarcinoma Based on Network Pharmacology Combined with Experimental Verification.
Zhang K; Chen X
Crit Rev Immunol; 2024; 44(5):27-40. PubMed ID: 38618726
[TBL] [Abstract] [Full Text] [Related]
2. Mesothelin promotes brain metastasis of non-small cell lung cancer by activating MET.
Xia S; Duan W; Xu M; Li M; Tang M; Wei S; Lin M; Li E; Liu W; Wang Q
J Exp Clin Cancer Res; 2024 Apr; 43(1):103. PubMed ID: 38570866
[TBL] [Abstract] [Full Text] [Related]
3. Tanshinone IIA induces ER stress and JNK activation to inhibit tumor growth and enhance anti-PD-1 immunotherapy in non-small cell lung cancer.
Zhang YZ; Lai HL; Huang C; Jiang ZB; Yan HX; Wang XR; Xie C; Huang JM; Ren WK; Li JX; Zhai ZR; Yao XJ; Wu QB; Leung EL
Phytomedicine; 2024 Jun; 128():155431. PubMed ID: 38537440
[TBL] [Abstract] [Full Text] [Related]
4. Curcumin-Piperlongumine Hybrid Molecule Increases Cell Cycle Arrest and Apoptosis in lung cancer through JNK/c-jun Signaling Pathway.
Zhang Q; Hui M; Chen G; Huang H; Wang S; Ye Y; Wang Y; Wang M; Zhang S; Huang L; Zhang F; Liu Z
J Agric Food Chem; 2024 Apr; 72(13):7244-7255. PubMed ID: 38517372
[TBL] [Abstract] [Full Text] [Related]
5. Dihydroartemisinin, a potential PTGS1 inhibitor, potentiated cisplatin-induced cell death in non-small cell lung cancer through activating ROS-mediated multiple signaling pathways.
Ni L; Zhu X; Zhao Q; Shen Y; Tao L; Zhang J; Lin H; Zhuge W; Cho YC; Cui R; Zhu W
Neoplasia; 2024 May; 51():100991. PubMed ID: 38507887
[TBL] [Abstract] [Full Text] [Related]
6. Clinical Efficacy and Gut Microbiota Regulating-Related Effect of Si-jun-Zi Decoction in Postoperative Non-Small Cell lung cancer Patients: A Prospective Observational Study.
He Y; Qi A; Gu Y; Zhang C; Wang Y; Yang W; Bi L; Gong Y; Jiao L; Xu L
Integr Cancer Ther; 2024; 23():15347354241237973. PubMed ID: 38504436
[TBL] [Abstract] [Full Text] [Related]
7. Antiproliferative and immunomodulative potential of Citrullus colocynthis and its bioactive compounds in human lymphocytes and lung cells.
Stein C; Voigts J; Niederreiter L; Kowarschik S; Huber R; Lüth VM
J Ethnopharmacol; 2024 Jun; 328():118053. PubMed ID: 38499257
[TBL] [Abstract] [Full Text] [Related]
8. Systematic identification of a synthetic lethal interaction in brain-metastatic lung adenocarcinoma.
Moon JW; Hong BJ; Kim SK; Park MS; Lee H; Lee J; Kim MY
Cancer Lett; 2024 Apr; 588():216781. PubMed ID: 38494150
[TBL] [Abstract] [Full Text] [Related]
9. CLDN6 inhibited cellular biological function of nonsmall cell lung cancer cells through suppressing aerobic glycolysis via the RIP1/ASK1/JNK axis.
Guo H; Li J; Dong Y; Gao H; Wang P
J Biochem Mol Toxicol; 2024 Mar; 38(3):e23682. PubMed ID: 38462752
[TBL] [Abstract] [Full Text] [Related]
10. [Mechanism of n-butanol fraction of Wenxia Formula combining with gefitinib in treating non-small cell lung cancer based on network pharmacology and in vitro experiment].
Chen RJ; Bi QY; Shi JM; Zhong J; Han JT; Ji XM
Zhongguo Zhong Yao Za Zhi; 2024 Jan; 49(2):471-486. PubMed ID: 38403323
[TBL] [Abstract] [Full Text] [Related]
11. miR-147b mediated suppression of DUSP8 promotes lung cancer progression.
Turkowski K; Herzberg F; Günther S; Weigert A; Haselbauer T; Fink L; Brunn D; Grimminger F; Seeger W; Sültmann H; Stiewe T; Pullamsetti SS; Savai R
Oncogene; 2024 Apr; 43(16):1178-1189. PubMed ID: 38396293
[TBL] [Abstract] [Full Text] [Related]
12. Small-molecule inhibition of MAP2K4 is synergistic with RAS inhibitors in
Jansen RA; Mainardi S; Dias MH; Bosma A; van Dijk E; Selig R; Albrecht W; Laufer SA; Zender L; Bernards R
Proc Natl Acad Sci U S A; 2024 Feb; 121(9):e2319492121. PubMed ID: 38377196
[TBL] [Abstract] [Full Text] [Related]
13. RhoGDIβ inhibition via miR-200c/AUF1/SOX2/miR-137 axis contributed to lncRNA MEG3 downregulation-mediated malignant transformation of human bronchial epithelial cells.
Yang Y; Tian Z; He L; Meng H; Xie X; Yang Z; Wang X; Zhao Y; Huang C
Mol Carcinog; 2024 May; 63(5):977-990. PubMed ID: 38376344
[TBL] [Abstract] [Full Text] [Related]
14. Propyl gallate induces human pulmonary fibroblast cell death through the regulation of Bax and caspase-3.
Park WH
Ann Med; 2024 Dec; 56(1):2319853. PubMed ID: 38373208
[TBL] [Abstract] [Full Text] [Related]
15. Dual-energy computed tomography for evaluating nodal staging in lung adenocarcinoma: correlation with surgical pathology.
Huang HC; Huang YS; Chang YC; Shih JY; Chen JS; Chang YC; Wang TC
Jpn J Radiol; 2024 May; 42(5):468-475. PubMed ID: 38311704
[TBL] [Abstract] [Full Text] [Related]
16. ANKRD1 is a mesenchymal-specific driver of cancer-associated fibroblast activation bridging androgen receptor loss to AP-1 activation.
Mazzeo L; Ghosh S; Di Cicco E; Isma J; Tavernari D; Samarkina A; Ostano P; Youssef MK; Simon C; Dotto GP
Nat Commun; 2024 Feb; 15(1):1038. PubMed ID: 38310103
[TBL] [Abstract] [Full Text] [Related]
17. Network pharmacology study to explore the multiple molecular mechanism of SH003 in the treatment of non-small cell lung cancer.
Lee K; Choi YJ; Lim HI; Cho KJ; Kang N; Ko SG
BMC Complement Med Ther; 2024 Feb; 24(1):70. PubMed ID: 38303001
[TBL] [Abstract] [Full Text] [Related]
18. Targeting MAPK signaling: A promising approach for treating inflammatory lung disease.
Saleem S
Pathol Res Pract; 2024 Feb; 254():155122. PubMed ID: 38246034
[TBL] [Abstract] [Full Text] [Related]
19. The APE1/REF-1 and the hallmarks of cancer.
Siqueira PB; de Sousa Rodrigues MM; de Amorim ÍSS; da Silva TG; da Silva Oliveira M; Rodrigues JA; de Souza da Fonseca A; Mencalha AL
Mol Biol Rep; 2024 Jan; 51(1):47. PubMed ID: 38165468
[TBL] [Abstract] [Full Text] [Related]
20. Hypoxia-induced activation of NDR2 underlies brain metastases from Non-Small Cell lung cancer.
Levallet J; Biojout T; Bazille C; Douyère M; Dubois F; Ferreira DL; Taylor J; Teulier S; Toutain J; Elie N; Bernaudin M; Valable S; Bergot E; Levallet G
Cell Death Dis; 2023 Dec; 14(12):823. PubMed ID: 38092743
[TBL] [Abstract] [Full Text] [Related]
[Next]
